Surrozen, Inc. (SRZN)
NASDAQ·Healthcare·Biotechnology
$30.87
+3.07%
Mkt Cap $227.49M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$40.00
Range $40.00 – $40.00
Implied Upside
+29.6%
Consensus $40.00 vs current $30.87
NASDAQ·Healthcare·Biotechnology
$30.87
+3.07%
Mkt Cap $227.49M
No recent rating data.
Price Target (3 analysts)
$40.00
Range $40.00 – $40.00
+29.6%
Consensus $40.00 vs current $30.87